 MADISON, Wis. , Nov. 1, 2022 PRNewswire -- Exact Sciences Corp. Nasdaq: EXAS, a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. 